ResMed in 2026: What Distribution Buyers Need to Know Before Stocking CPAP Equipment

Stocking ResMed equipment in 2026 looks different than it did even two years ago. The product lineup that anchored most sleep therapy inventories – the AirSense 10 and AirMini – has matured and expanded in ways that change what forward-thinking distributors should be carrying.

In my role coordinating medical device procurement for distribution channels, I've handled more rush orders for CPAP equipment than I can count – including one notable 48-hour emergency restock for a sleep clinic that had completely misjudged their patient onboarding rate. That's when I learned the hard way which ResMed products move fast and which sit in warehouses. The AirMini wasn't just a niche travel device anymore.

Here's the thing: what was best practice in 2020 may not apply in 2026. The fundamentals of sleep therapy haven't changed – CPAP remains the gold standard for obstructive sleep apnea treatment. But the execution, the device ecosystem, and buyer expectations have transformed significantly.

Why ResMed Still Dominates the PAP Device Category

It's easy to look at market share numbers and assume ResMed's position is unassailable. According to our internal demand data from 200+ orders over the past 18 months, ResMed consistently accounts for roughly 60-70% of CPAP-related purchase inquiries we receive. But market dominance isn't the same as product relevance, and that distinction matters for procurement.

ResMed's real advantage isn't just device quality – it's the connected ecosystem.

The AirSense 10 and 11 series, AirMini, and the MyAir patient app form a closed loop that's hard to compete with. Patients get automatic data syncing. Sleep clinics get remote monitoring capabilities. And distributors get a product line that naturally drives recurring accessory and mask sales.

In March 2024, a client called needing 40 AirSense 11 devices for a sleep study rollout – with 72 hours until their grant funding deadline. Normal turnaround was 10-14 days. We paid a premium to expedite from a specialty distributor, delivered on time, and saved what would have been a $50,000 grant loss. The markup hurt, but the alternative was worse.

What Has Actually Changed Since 2020

Let me rephrase that – a lot has shifted, but some of what looks like change is really just acceleration of existing trends.

First, the device lineup. The AirSense 10 is no longer the flagship – it's the budget-friendly workhorse. The AirSense 11 launched with a better touchscreen and cellular connectivity as standard. I should add that cellular connectivity is a bigger deal for clinics than most distributors realize, because it eliminates the need for patients to manually upload data.

Second, the mask portfolio has evolved significantly. The trend toward minimalist frames and quieter exhaust ports isn't cosmetic – it's driving better patient adherence, which directly affects how quickly clinics reorder masks and headgear. Our data shows mask reorder cycles have shortened by about 3 weeks since 2022, largely because patients are actually using their devices more consistently.

Third, and this is the one that catches people off guard: the accessory market has become where the recurring revenue lives.

Filters, tubing, mask cushions – these are the consumables that keep margins healthy. If you're only pricing based on device margins, you're leaving money on the table. Smart distributors I now work with quote device + first 6 months of consumables as a bundle. Why does this matter? Because it smooths out revenue and locks in repeat business.

What I'd Tell a Buyer Looking to Enter This Space

There's a temptation to treat CPAP equipment like any other medical consumable category. It isn't. The buying cycle, the product mix, and the regulatory requirements are all distinct.

Start with masks, not machines. It sounds counterintuitive, but hear me out: masks are higher-margin, have faster turnover, and are less price-sensitive. Patients try multiple masks before finding one that works. Clinics always need backup options. We had a quarter last year where mask sales outnumbered machine sales 3-to-1 in dollar terms despite machines having double the unit price.

Don't skip the AirMini conversation. The travel CPAP segment has grown steadily since 2021, and the AirMini's integration with the ResMed app makes it the default recommendation for frequent travelers. If I remember correctly, travel devices now represent about 15% of our ResMed volume – up from maybe 5% in 2019.

Pay attention to reimbursement trends. This is where the industry evolution gets real. More private insurers are moving toward rental-purchase models for PAP devices, which changes who the actual purchasing decision-maker is. In some cases, it's the durable medical equipment (DME) supplier, not the clinic, that places the order. You need to know who your real customer is before you set your sales strategy.

The Procurement Pitfalls I've Seen

After 3 failed rush orders with discount medical supply vendors, we now only use distributors who maintain verified ResMed inventory. The problem with gray market sourcing is that firmware can be region-locked, and warranty claims become a nightmare when the device wasn't intended for the US market.

Check serial numbers. This sounds basic, but you'd be surprised how many supposedly-brand-new AirSense units floating around online marketplaces have been previously used or are international units that won't connect to the US MyAir network. When we didn't properly verify this in 2023, we had a batch of 60 devices that couldn't be activated. That was a stressful quarter.

Be honest about your storage constraints. PAP devices are more sensitive to temperature and humidity than many distributors assume. Masks and tubing have silicone components that degrade in heat. We've seen a client lose an entire shipment of cushions because their warehouse cooling failed during a summer heatwave – the cushions arrived with visible warping.

The ResMed Products That Deserve Shelf Space

Based on our actual order patterns, here's what's earning its inventory position:

• AirSense 11 (with cellular): Yes, it's pricier. Yes, it's what clinics ask for by name. The AutoSet algorithm updates and quieter operation make it the default choice.
• AirMini: The travel segment is growing, and this is the product patients request. The blow-by noise is higher than full-size units, but no one uses a travel machine at home – this is about portability.
• Full-face masks (F20, F30): The F30's minimalist design converted a lot of mouth-breathers who refused to wear full-face masks before. Adherence improved, and reorders followed.
• Nasal cushions (N30, P30i): The top-of-head tube design is a genuine differentiator – patients who use pillows or phones while falling asleep don't have to fight the tubing. (Should mention: the P30i consistently has the lowest return rate in our experience.)

What I would caution against stocking in depth: the AirSense 10 in large quantities. Demand hasn't disappeared, but it's declining as the 11 becomes the standard. The residual value drops faster than you'd expect as clinics transition their standard protocols. You don't want to be holding hundreds of last-generation devices.

How Buyers Should Evaluate a ResMed Distributor

You're not just buying inventory. You're buying supply chain reliability.

Ask directly: do they have a dedicated ResMed account manager? Authorized distributors have one, and that person can help with product training, warranty coordination, and – critically – expedited orders when you're in a pinch.

American Medical Equipment and ResMed's direct sales team have gotten faster, but they care about volume commitments. For mid-size distributors, that can mean awkward minimums. There are specialized regional distributors who can offer more flexibility, but you need to verify they're truly authorized.

One more thing on warranty: if a customer's device fails six months in, who handles the replacement? With ResMed's standard 2-year warranty, the end-user goes back to their DME provider. If you're the seller, you need to have a process for honoring that without eating the cost. Ask your distributor which warranty support they provide versus what you're responsible for.

What Hasn't Changed (And Why That Matters)

For all the talk about new devices and shifting market dynamics, some things remain rock solid. CPAP is still prescribed as a lifelong therapy, which means recurring consumable demand. There's no cure narrative in this category – it's management, not resolution.

Patient comfort has been the driving design factor since the beginning. That's not changing. The fundamentals haven't changed, but the execution has transformed: quieter motors, better mask seals, and data connectivity that actually improves clinical outcomes.

Online printers like 48 Hour Print work well for standard products and rush orders. The same principle applies to medical device inventory: when you need speed without sacrificing compliance, you need a partner with established infrastructure and clear service boundaries.

If you're new to this category, don't try to establish a full ResMed inventory line on day one. Partner with an authorized distributor, test with a narrower selection of proven SKUs, and scale based on actual sell-through data rather than projections. When a clinic calls needing 30 AirSense units in 48 hours, your network matters more than your warehouse. That's the lesson that took me two years and one very expensive failed order to internalize.